The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Peptide APIs Market Research Report 2025
Synopsis
Fully extensible peptide active pharmaceutical ingredients (apis) from early clinical to commercial products because the different physiological parts of peptides make them appropriate support masters changes.There is a broad array of physiological activities influenced by bioactive peptides, and these biological activities are controlled by the type, number, progression, and nature of the amino acids shown in the peptides.
The global Peptide APIs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Peptide APIs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Peptide APIs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Peptide APIs include CordenPharma, PolyPeptide, Bachem, AmbioPharm, Pepscan, BCN Peptides and Senn Chemicals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Peptide APIs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide APIs.
Report Scope
The Peptide APIs market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Peptide APIs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peptide APIs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CordenPharma
PolyPeptide
Bachem
AmbioPharm
Pepscan
BCN Peptides
Senn Chemicals
Segment by Type
Liquid Phase Peptide Synthesis (LPPS)
Solid Phase Peptide Synthesis (SPPS)
Segment by Application
Cancer
Diabetes
Obesity
Fertility
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Peptide APIs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Peptide APIs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Fully extensible peptide active pharmaceutical ingredients (apis) from early clinical to commercial products because the different physiological parts of peptides make them appropriate support masters changes.There is a broad array of physiological activities influenced by bioactive peptides, and these biological activities are controlled by the type, number, progression, and nature of the amino acids shown in the peptides.
The global Peptide APIs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Peptide APIs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Peptide APIs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Peptide APIs include CordenPharma, PolyPeptide, Bachem, AmbioPharm, Pepscan, BCN Peptides and Senn Chemicals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Peptide APIs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide APIs.
Report Scope
The Peptide APIs market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Peptide APIs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peptide APIs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CordenPharma
PolyPeptide
Bachem
AmbioPharm
Pepscan
BCN Peptides
Senn Chemicals
Segment by Type
Liquid Phase Peptide Synthesis (LPPS)
Solid Phase Peptide Synthesis (SPPS)
Segment by Application
Cancer
Diabetes
Obesity
Fertility
Other
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Peptide APIs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Peptide APIs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Peptide APIs Market Overview
1.1 Product Overview and Scope of Peptide APIs
1.2 Peptide APIs Segment by Type
1.2.1 Global Peptide APIs Market Value Comparison by Type (2024-2030)
1.2.2 Liquid Phase Peptide Synthesis (LPPS)
1.2.3 Solid Phase Peptide Synthesis (SPPS)
1.3 Peptide APIs Segment by Application
1.3.1 Global Peptide APIs Market Value by Application: (2024-2030)
1.3.2 Cancer
1.3.3 Diabetes
1.3.4 Obesity
1.3.5 Fertility
1.3.6 Other
1.4 Global Peptide APIs Market Size Estimates and Forecasts
1.4.1 Global Peptide APIs Revenue 2019-2030
1.4.2 Global Peptide APIs Sales 2019-2030
1.4.3 Global Peptide APIs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Peptide APIs Market Competition by Manufacturers
2.1 Global Peptide APIs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Peptide APIs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Peptide APIs Average Price by Manufacturers (2019-2024)
2.4 Global Peptide APIs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Peptide APIs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Peptide APIs, Product Type & Application
2.7 Peptide APIs Market Competitive Situation and Trends
2.7.1 Peptide APIs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Peptide APIs Players Market Share by Revenue
2.7.3 Global Peptide APIs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Peptide APIs Retrospective Market Scenario by Region
3.1 Global Peptide APIs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Peptide APIs Global Peptide APIs Sales by Region: 2019-2030
3.2.1 Global Peptide APIs Sales by Region: 2019-2024
3.2.2 Global Peptide APIs Sales by Region: 2025-2030
3.3 Global Peptide APIs Global Peptide APIs Revenue by Region: 2019-2030
3.3.1 Global Peptide APIs Revenue by Region: 2019-2024
3.3.2 Global Peptide APIs Revenue by Region: 2025-2030
3.4 North America Peptide APIs Market Facts & Figures by Country
3.4.1 North America Peptide APIs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Peptide APIs Sales by Country (2019-2030)
3.4.3 North America Peptide APIs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Peptide APIs Market Facts & Figures by Country
3.5.1 Europe Peptide APIs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Peptide APIs Sales by Country (2019-2030)
3.5.3 Europe Peptide APIs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Peptide APIs Market Facts & Figures by Country
3.6.1 Asia Pacific Peptide APIs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Peptide APIs Sales by Country (2019-2030)
3.6.3 Asia Pacific Peptide APIs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Peptide APIs Market Facts & Figures by Country
3.7.1 Latin America Peptide APIs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Peptide APIs Sales by Country (2019-2030)
3.7.3 Latin America Peptide APIs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Peptide APIs Market Facts & Figures by Country
3.8.1 Middle East and Africa Peptide APIs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Peptide APIs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Peptide APIs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Peptide APIs Sales by Type (2019-2030)
4.1.1 Global Peptide APIs Sales by Type (2019-2024)
4.1.2 Global Peptide APIs Sales by Type (2025-2030)
4.1.3 Global Peptide APIs Sales Market Share by Type (2019-2030)
4.2 Global Peptide APIs Revenue by Type (2019-2030)
4.2.1 Global Peptide APIs Revenue by Type (2019-2024)
4.2.2 Global Peptide APIs Revenue by Type (2025-2030)
4.2.3 Global Peptide APIs Revenue Market Share by Type (2019-2030)
4.3 Global Peptide APIs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Peptide APIs Sales by Application (2019-2030)
5.1.1 Global Peptide APIs Sales by Application (2019-2024)
5.1.2 Global Peptide APIs Sales by Application (2025-2030)
5.1.3 Global Peptide APIs Sales Market Share by Application (2019-2030)
5.2 Global Peptide APIs Revenue by Application (2019-2030)
5.2.1 Global Peptide APIs Revenue by Application (2019-2024)
5.2.2 Global Peptide APIs Revenue by Application (2025-2030)
5.2.3 Global Peptide APIs Revenue Market Share by Application (2019-2030)
5.3 Global Peptide APIs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 CordenPharma
6.1.1 CordenPharma Corporation Information
6.1.2 CordenPharma Description and Business Overview
6.1.3 CordenPharma Peptide APIs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 CordenPharma Peptide APIs Product Portfolio
6.1.5 CordenPharma Recent Developments/Updates
6.2 PolyPeptide
6.2.1 PolyPeptide Corporation Information
6.2.2 PolyPeptide Description and Business Overview
6.2.3 PolyPeptide Peptide APIs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 PolyPeptide Peptide APIs Product Portfolio
6.2.5 PolyPeptide Recent Developments/Updates
6.3 Bachem
6.3.1 Bachem Corporation Information
6.3.2 Bachem Description and Business Overview
6.3.3 Bachem Peptide APIs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bachem Peptide APIs Product Portfolio
6.3.5 Bachem Recent Developments/Updates
6.4 AmbioPharm
6.4.1 AmbioPharm Corporation Information
6.4.2 AmbioPharm Description and Business Overview
6.4.3 AmbioPharm Peptide APIs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 AmbioPharm Peptide APIs Product Portfolio
6.4.5 AmbioPharm Recent Developments/Updates
6.5 Pepscan
6.5.1 Pepscan Corporation Information
6.5.2 Pepscan Description and Business Overview
6.5.3 Pepscan Peptide APIs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Pepscan Peptide APIs Product Portfolio
6.5.5 Pepscan Recent Developments/Updates
6.6 BCN Peptides
6.6.1 BCN Peptides Corporation Information
6.6.2 BCN Peptides Description and Business Overview
6.6.3 BCN Peptides Peptide APIs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 BCN Peptides Peptide APIs Product Portfolio
6.6.5 BCN Peptides Recent Developments/Updates
6.7 Senn Chemicals
6.6.1 Senn Chemicals Corporation Information
6.6.2 Senn Chemicals Description and Business Overview
6.6.3 Senn Chemicals Peptide APIs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Senn Chemicals Peptide APIs Product Portfolio
6.7.5 Senn Chemicals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Peptide APIs Industry Chain Analysis
7.2 Peptide APIs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Peptide APIs Production Mode & Process
7.4 Peptide APIs Sales and Marketing
7.4.1 Peptide APIs Sales Channels
7.4.2 Peptide APIs Distributors
7.5 Peptide APIs Customers
8 Peptide APIs Market Dynamics
8.1 Peptide APIs Industry Trends
8.2 Peptide APIs Market Drivers
8.3 Peptide APIs Market Challenges
8.4 Peptide APIs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
